March 3, 2008 - Boston Scientific Corp. received CE Mark approval of its ACUITY Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, marking the company�s seventh U.S. or European regulatory approval in the past nine weeks.
The devices, which both treat heart failure, are equipped with ACUITY Spiral left ventricular lead designed with a small lead tip profile (4 French) for placement of the lead even in difficult-to-access veins of varying sizes.
The ACUITY Spiral lead is pending approval by the U.S. Food and Drug Administration and is not available for sale in the United States.
For more information: www.bostonscientific.com
